PLOS ONE RSS
scienceLeft
Reprogramming M2 macrophages via TLR7/8 agonist-loaded hollow MnO<sub>2</sub> nanovehicles to suppress the progression of liver cancertranslating…
by Pei-pei He, Zheng-ju Hou, Han-mei Li, Ji-xuan Zhang, An-Qi Chen, Quan-you Miao, Chao-Feng Yang, Jin-hong Yu, Yang Li
As a prevalent malignancy, liver cancer ranks as the third most common cause of cancer mortality globally. Within the tumor microenvironment, tumor-associated…
Keywords#cancer#li#M2#Reprogramming#Reprogramming M2